290 related articles for article (PubMed ID: 31278984)
1. Relation of oxidized-low-density lipoprotein and high-density lipoprotein subfractions in non-treated patients with coronary artery disease.
Zhao X; Zhang HW; Sun D; Xu RX; Guo YL; Sun J; Zhu CG; Wu NQ; Zhang Y; Li S; Li JJ
Prostaglandins Other Lipid Mediat; 2019 Oct; 144():106345. PubMed ID: 31278984
[TBL] [Abstract][Full Text] [Related]
2. Low-density lipoprotein-associated variables and the severity of coronary artery disease: an untreated Chinese cohort study.
Zhao X; Sun D; Xu RX; Guo YL; Zhu CG; Wu NQ; Zhang Y; Li S; Gao Y; Liu G; Dong Q; Li JJ
Biomarkers; 2018 Nov; 23(7):647-653. PubMed ID: 29730953
[TBL] [Abstract][Full Text] [Related]
3. Relationship between plasma phospholipase A2 concentrations and lipoprotein subfractions in patients with stable coronary artery disease.
Xu RX; Zhang Y; Li XL; Li S; Guo YL; Dong Q; Liu G; Li JJ
Clin Chim Acta; 2015 Jun; 446():195-200. PubMed ID: 25934512
[TBL] [Abstract][Full Text] [Related]
4. Circulating non-HDL-C levels were more relevant to atherogenic lipoprotein subfractions compared with LDL-C in patients with stable coronary artery disease.
Zhu CG; Zhang Y; Xu RX; Li S; Wu NQ; Guo YL; Sun J; Li JJ
J Clin Lipidol; 2015; 9(6):794-800. PubMed ID: 26687700
[TBL] [Abstract][Full Text] [Related]
5. Serum high-density lipoprotein-cholesterol levels modify the association between plasma levels of oxidatively modified low-density lipoprotein and coronary artery disease in men.
Zhang B; Bai H; Liu R; Kumagai K; Itabe H; Takano T; Saku K
Metabolism; 2004 Apr; 53(4):423-9. PubMed ID: 15045686
[TBL] [Abstract][Full Text] [Related]
6. Relationships of low density lipoprotein subfractions to angiographically defined coronary artery disease in young survivors of myocardial infarction.
Tornvall P; Karpe F; Carlson LA; Hamsten A
Atherosclerosis; 1991 Sep; 90(1):67-80. PubMed ID: 1799399
[TBL] [Abstract][Full Text] [Related]
7. High-density lipoprotein subfractions in relation with the severity of coronary artery disease: A Gensini score assessment.
Xu RX; Li S; Li XL; Zhang Y; Guo YL; Zhu CG; Wu NQ; Qing P; Sun J; Dong Q; Li JJ
J Clin Lipidol; 2015; 9(1):26-34. PubMed ID: 25670357
[TBL] [Abstract][Full Text] [Related]
8. Impact of short-term low-dose atorvastatin on low-density lipoprotein and high-density lipoprotein subfraction phenotype.
Xu RX; Guo YL; Li XL; Li S; Li JJ
Clin Exp Pharmacol Physiol; 2014 Jul; 41(7):475-81. PubMed ID: 24739131
[TBL] [Abstract][Full Text] [Related]
9. Relation of plasma PCSK9 levels to lipoprotein subfractions in patients with stable coronary artery disease.
Xu RX; Li S; Zhang Y; Li XL; Guo YL; Zhu CG; Li JJ
Lipids Health Dis; 2014 Dec; 13():188. PubMed ID: 25496400
[TBL] [Abstract][Full Text] [Related]
10. Administration of eicosapentaenoic acid may alter lipoprotein particle heterogeneity in statin-treated patients with stable coronary artery disease: A pilot 6-month randomized study.
Tani S; Yagi T; Matsuo R; Kawauchi K; Atsumi W; Matsumoto N; Okumura Y
J Cardiol; 2020 Nov; 76(5):487-498. PubMed ID: 32636128
[TBL] [Abstract][Full Text] [Related]
11. Analysis of Lipoprotein Subfractions in Chinese Han Patients with Stable Coronary Artery Disease.
Xu RX; Zhang Y; Ye P; Chen H; Li YF; Hua Q; Guo YL; Li XL; Li S; Dong Q; Liu G; Li JJ
Heart Lung Circ; 2015 Dec; 24(12):1203-10. PubMed ID: 26105990
[TBL] [Abstract][Full Text] [Related]
12. Biochemical markers of vasospastic coronary artery disease.
Yamaguchi H; Homma Y; Handa S
Nutr Metab Cardiovasc Dis; 2003 Dec; 13(6):365-71. PubMed ID: 14979683
[TBL] [Abstract][Full Text] [Related]
13. HDL
Chaudhary R; Kinderytė M; Chaudhary R; Sukhi A; Bliden K; Tantry U; Gurbel P
Cardiovasc Revasc Med; 2019 Nov; 20(11):1001-1006. PubMed ID: 30626544
[TBL] [Abstract][Full Text] [Related]
14. Elevated resting heart rate is associated with the severity of coronary artery disease in non-treated patients who underwent coronary angiography: potential role of lipoprotein subfractions.
Zhang Y; Wu NQ; Xu RX; Li S; Zhu CG; Guo YL; Gao Y; Qing P; Cui CJ; Sun J; Li JJ
Arch Physiol Biochem; 2017 Dec; 123(5):356-363. PubMed ID: 28686483
[TBL] [Abstract][Full Text] [Related]
15. The oxidation ratio of LDL: a predictor for coronary artery disease.
Huang H; Mai W; Liu D; Hao Y; Tao J; Dong Y
Dis Markers; 2008; 24(6):341-9. PubMed ID: 18688083
[TBL] [Abstract][Full Text] [Related]
16. Association between moderately oxidized low-density lipoprotein and high-density lipoprotein particle subclass distribution in hemodialyzed and post-renal transplant patients.
Kimak E; Hałabiś M; Baranowicz-Gąszczyk I; Solski J; Książek A
J Zhejiang Univ Sci B; 2011 May; 12(5):365-71. PubMed ID: 21528490
[TBL] [Abstract][Full Text] [Related]
17. Circulating Oxidized Low-Density Lipoprotein is a Strong Risk Factor for the Early Stage of Coronary Heart Disease.
Zhang Q; Ai Y; Dong H; Wang J; Xu L
IUBMB Life; 2019 Feb; 71(2):277-282. PubMed ID: 30414358
[TBL] [Abstract][Full Text] [Related]
18. Small LDL subfractions are associated with coronary atherosclerosis despite no differences in conventional lipids.
Sæther JC; Klevjer M; Giskeødegård GF; Bathen TF; Gigante B; Gjære S; Myhra M; Vesterbekkmo EK; Wiseth R; Madssen E; Bye A
Physiol Genomics; 2023 Jan; 55(1):16-26. PubMed ID: 36374174
[TBL] [Abstract][Full Text] [Related]
19. HDL subpopulations containing apoA-I without apoA-II (LpA-I) in patients with angiographically proven coronary artery disease.
Kuchta A; Strzelecki A; Ćwiklińska A; Gruchała M; Zdrojewski Z; Kortas-Stempak B; Wieczorek E; Gliwińska A; Dąbkowski K; Jankowski M
J Cardiol; 2017 Mar; 69(3):523-528. PubMed ID: 27169356
[TBL] [Abstract][Full Text] [Related]
20. High density-lipoprotein subfractions of patients using cardio-selective beta-blockers.
Kuster GM; Amann FW; Neuenschwander C; Drexel H
Cardiovasc Drugs Ther; 2002 Mar; 16(2):127-31. PubMed ID: 12090905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
